Venclose
San Jose, US · Delaware corporation · 2 known investors
Find your way into Venclose
Sign up to see every warm intro you have to Venclose
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Venclose team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Investors · 2
Ally Bridge GroupreportedNew York
How we know: funding news · ally-bridge.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$27.1M disclosed across 1 round · 2019
▶$27.1MraisedNov 2019 · 67 investors · Other Health CareRule 506(b)
▶$27.1MraisedNov 2019 · 67 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Greg VislockyDirector
- Charles ChonDirector
- Jason TurnerExecutive Officer
- Peter OsborneExecutive Officer, Director
- Jerry GibsonExecutive Officer, Director
- Offering amount
- $27.1M
- Amount sold
- $27.1M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Venclose's investors?
- Venclose's investors include SCP Ventures, LLC, Ally Bridge Group.
- How much funding has Venclose raised?
- Venclose has disclosed $27.1M raised across 1 round.
- Where is Venclose headquartered?
- Venclose is headquartered in San Jose, US.
